Cardiology Today


The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
5 Questions

L. Kristin Newby, MD, MHS, ponders path from lab to clinic

Cardiology Today Anniversary

2 decades of molecular cardiology and genetics

Robert Roberts, MD, FRCPC, MACC, FRSC, LLD (Hon.)

Cover Story

CV complications of pregnancy: A call for greater awareness

FDA News

FDA approves BevyxXa for prevention of venous thromboembolism

FDA committee supports expanded CV indication for liraglutide in adults with type 2 diabetes

Self-expanding TAVR system approved for use in intermediate-risk patients


Monogenic, polygenic risk for CVD may be lowered by lifestyle changes, statin therapy

Awareness of women’s CV health, CVD risk low among patients, physicians

Q&A: Nieca Goldberg, MD, discusses strategies to encourage CV awareness

In the Journals

Intensive BP lowering may reduce risk for LV hypertrophy

HF malignancy similar to certain cancers

Improved diet quality may reduce risk for death

HF hospitalizations remain more common in men, black patients

UTROPIA: Single high-sensitivity cardiac troponin I measurement at presentation may rule out acute MI

Running and the heart: Multiple marathons do not raise atherosclerosis risk

Herpes zoster linked to elevated risk for MI, stroke

Health care expansion through ACA may have reduced incidence of cardiac arrest

NIH funding for cardiac arrest research decreased in past 10 years

New-generation DES consistent, durable over 3 years in women with acute MI

Pregnancy complications increase risk for premature CHD in adults

Patients with ICDs may engage in sports

Long-term aspirin use in older patients increases risk for major bleeding

Systolic BP levels below guideline targets may decrease CVD, mortality risk

Select traditional Chinese medicine may benefit patients with heart disease

Minor lifestyle improvements may decrease high BP risk in black adults

Cardiology care soon after AF diagnosis tied to lower stroke risk

ATHOS-3: Angiotensin II may increase BP in patients with vasodilatory shock

Cocaine abuse harms CV system

Clonal hematopoiesis of indeterminate potential increases CHD risk

Adherence to lipid-management guidelines benefits patients with CLI

ACC committee: Sex disparities evident in heart health care

ANGPTL3 antagonism may further decrease lipid levels, risk for CVD

AHA: Polyunsaturated fats as substitute for saturated fats lower risk for CVD

Compound intervention fails to improve readmission, medication adherence after acute MI

DAPT score can identify patients who may benefit from shorter DAPT

Direct oral anticoagulants may be underprescribed to patients with AF, high stroke risk

Fat tissue measurement with CTA may prevent MI, CVD

In the Journals Plus

Idarucizumab safely reverses anticoagulant effect of dabigatran

Industry News

Ralinepag may improve pulmonary vascular resistance in patients with PAH

USPSTF recommends screening for obesity in children, adolescents

REVEAL: Anacetrapib plus atorvastatin reduces coronary events in high-risk patients

Meeting News

Reactive antitachycardia pacing therapy linked to lower AF progression rates

DEVOTE: Insulin degludec demonstrates CV safety, reduced risk for severe hypoglycemia

AUGMENT-HF: Implant procedure continues to benefit patients with HF

CVD-REAL: SGLT2 inhibitors benefit patients with diabetes, irrespective of CV history

Pharmacology Consult

Patient-specific pharmacotherapy plan may reduce HF hospitalizations

Jeremy Moretz, PharmD, BCPS

Trial Scorecards

Trial Scorecard: TREAT-AF

Trial Scorecard: ACIST-FFR

Trial Scorecard: CVD-REAL

Trial Scorecard: PESA

Trial Scorecard: AUGMENT-HF

Trial Scorecard: DEVOTE

Trial Scorecard: AEIOU

Trial Scorecard: AKI-MATRIX